Sangamo Therapeutics
SGMO
#10419
Rank
S$39.55 M
Marketcap
S$0.09547
Share price
0.00%
Change (1 day)
-87.37%
Change (1 year)

Sangamo Therapeutics (SGMO) - Net assets

Net assets on the balance sheet as of March 2026 : -S$24.46 Million

According to Sangamo Therapeutics 's latest financial reports the company has -S$24.46 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Sangamo Therapeutics - Net assets on balance sheet (from 2001 to 2026)

Net assets by year

Year Net assets Change
2025-12-31$-S$18.32 Million-159.19%
2024-12-31$S$30.95 M-71.73%
2023-12-31$S$0.10 B-72.32%
2022-12-31$S$0.39 B-22.07%
2021-12-31$S$0.50 B-22.88%
2020-12-31$S$0.65 B12.78%
2019-12-31$S$0.58 B16.28%
2018-12-31$S$0.50 B99.64%
2017-12-31$S$0.25 B27.5%
2016-12-31$S$0.19 B-27.59%
2015-12-31$S$0.27 B-0.3%
2014-12-31$S$0.27 B77.06%
2013-12-31$S$0.15 B94.31%
2012-12-31$S$79.36 M-23.53%
2011-12-31$S$0.10 B44.1%
2010-12-31$S$72.01 M-28.54%
2009-12-31$S$0.10 B27.21%
2008-12-31$S$79.22 M-23.67%
2007-12-31$S$0.10 B38.96%
2006-12-31$S$74.68 M18.62%
2005-12-31$S$62.96 M19.2%
2004-12-31$S$52.81 M-30.39%
2003-12-31$S$75.87 M-19.38%
2002-12-31$S$94.12 M-38.26%
2001-12-31$S$0.15 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Johnson & Johnson
JNJ
S$104.73 B-428,409.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$11.85 B-48,583.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$24.06 B-98,499.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
S$21.62 B-88,535.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
S$30.22 B-123,713.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$59.25 B-242,416.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
S$1.38 B-5,773.33%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$8.01 B-32,872.94%๐Ÿ‡บ๐Ÿ‡ธ USA